ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ADVM Adverum Biotechnologies Inc

9.30
-0.31 (-3.23%)
After Hours
Last Updated: 16:14:33
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Adverum Biotechnologies Inc ADVM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.31 -3.23% 9.30 16:14:33
Open Price Low Price High Price Close Price Prev Close
9.45 9.19 10.76 9.30 9.61
more quote information »

Recent News

Date Time Source Heading
5/09/202416:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202416:10EDGAR2Form 8-K - Current report
5/09/202416:05GLOBEAdverum Biotechnologies Reports First Quarter 2024 Financial..
5/03/202408:00GLOBEAdverum Biotechnologies to Participate in Upcoming May..
4/25/202416:05GLOBEAdverum Biotechnologies to Present LUNA 26-week Phase 2..
3/18/202416:05GLOBEAdverum Biotechnologies Reports Fourth Quarter and Full Year..
3/04/202416:40EDGAR2Form S-3 - Registration statement under Securities Act of..
2/28/202416:05GLOBEAdverum Biotechnologies to Participate in the TD Cowen 44th..
2/22/202415:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/21/202415:39EDGAR2Form D - Notice of Exempt Offering of Securities
2/15/202416:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202420:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202416:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202416:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202416:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202408:00GLOBEAdverum Biotechnologies to Participate in the Oppenheimer..
2/09/202417:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202411:41EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/08/202408:45EDGAR2Form 8-K - Current report
2/08/202407:00GLOBEAdverum Biotechnologies Announces Positive Preliminary..
2/06/202416:47EDGAR2Form 8-K - Current report
2/05/202417:03EDGAR2Form 8-K - Current report
2/05/202407:45GLOBEAdverum Biotechnologies Announces $127.5 Million Private..
2/01/202417:30GLOBEAdverum Biotechnologies will Host Webcast to Review LUNA..
1/29/202408:00GLOBEAdverum Biotechnologies Appoints Romuald Corbau, Ph.D. as..
12/08/202316:11EDGAR2Form 8-K - Current report
12/07/202316:05GLOBEAdverum Biotechnologies to Present LUNA Preliminary Efficacy..
12/04/202316:09EDGAR2Form 8-K/A - Current report: [Amend]
11/28/202316:05GLOBEAdverum Biotechnologies to Participate in the Evercore ISI..
11/09/202316:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202316:07EDGAR2Form 8-K - Current report
11/09/202316:05GLOBEAdverum Biotechnologies Reports Third Quarter 2023 Financial..
11/06/202319:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/06/202319:52EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/06/202316:10EDGAR2Form 8-K - Current report
11/06/202308:00GLOBEAdverum Biotechnologies Appoints C. David Nicholson, Ph.D...
11/04/202317:54GLOBEAdverum Biotechnologies Announces 3-Year Efficacy and Safety..
9/26/202316:05GLOBEAdverum Biotechnologies Announces Positive Aflibercept..
9/21/202316:05GLOBEAdverum Biotechnologies to Participate in Upcoming Investor..
9/18/202318:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/05/202316:05GLOBEAdverum Biotechnologies to Participate in the H.C...
8/21/202316:05GLOBEAdverum Biotechnologies Appoints Andrew Ramelmeier, Ph.D. as..
8/14/202308:00GLOBEAdverum Biotechnologies to Participate in the H.C...
8/10/202316:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202316:09EDGAR2Form 8-K - Current report
8/10/202316:05GLOBEAdverum Biotechnologies Completes Enrollment of Phase 2 LUNA..
8/04/202316:18EDGAR2Form 8-K - Current report
7/24/202316:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
6/12/202308:00GLOBEAdverum Biotechnologies Grants License to Ray Therapeutics..

Your Recent History

Delayed Upgrade Clock